Suh, S.H.; Choi, H.S.; Kim, C.S.; Kim, I.J.; Cha, H.; Cho, J.M.; Ma, S.K.; Kim, S.W.; Bae, E.H.
CG200745, a Novel HDAC Inhibitor, Attenuates Kidney Fibrosis in a Murine Model of Alport Syndrome. Int. J. Mol. Sci. 2020, 21, 1473.
https://doi.org/10.3390/ijms21041473
AMA Style
Suh SH, Choi HS, Kim CS, Kim IJ, Cha H, Cho JM, Ma SK, Kim SW, Bae EH.
CG200745, a Novel HDAC Inhibitor, Attenuates Kidney Fibrosis in a Murine Model of Alport Syndrome. International Journal of Molecular Sciences. 2020; 21(4):1473.
https://doi.org/10.3390/ijms21041473
Chicago/Turabian Style
Suh, Sang Heon, Hong Sang Choi, Chang Seong Kim, In Jin Kim, Hyunju Cha, Joong Myung Cho, Seong Kwon Ma, Soo Wan Kim, and Eun Hui Bae.
2020. "CG200745, a Novel HDAC Inhibitor, Attenuates Kidney Fibrosis in a Murine Model of Alport Syndrome" International Journal of Molecular Sciences 21, no. 4: 1473.
https://doi.org/10.3390/ijms21041473
APA Style
Suh, S. H., Choi, H. S., Kim, C. S., Kim, I. J., Cha, H., Cho, J. M., Ma, S. K., Kim, S. W., & Bae, E. H.
(2020). CG200745, a Novel HDAC Inhibitor, Attenuates Kidney Fibrosis in a Murine Model of Alport Syndrome. International Journal of Molecular Sciences, 21(4), 1473.
https://doi.org/10.3390/ijms21041473